Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Luspatercept in Beta-Thalassemia
NCT01749540Phase 2Completed
- Start
- Feb 2013
- Primary completion
- Nov 2015
- Modality
- Fc-Fusion Proteins
- Countries
- 2
01
Overview
A Phase 2 trial of luspatercept in beta thalassemia. Started Feb 2013; status: completed.
02
Drugs
luspatercept
03
Conditions
beta thalassemia
Beyond the preview
Go deeper on NCT01749540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01749540.